| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02289144 Details | 2019-07-30 Interventional | 2 | 0 | Ceritinib Thyroid Carcino… Thyroid Disease… Thyroid Neoplas… Locally Advance… Metastatic Anap… | study was on hold for protocol redesign; decided to not move forward with study. - | |||
| NCT00167180 NCT00303693 Details | 2019-07-30 Interventional | 2 | 57 | Cyclophosphamid… Leukemia Leukemia, Lymph… Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Multiple Myelom… Myelodysplastic… Precursor Cell … AML Leukemia, Lymph… Leukemia, Lymph… Leukemia, Myelo… Lymphomas Myelodysplastic… | Accrual Goal Met - | |||
| NCT02908516 Details | 2019-07-29 Interventional | 4 | 6 | Tranexamic Acid Fractures, Bone Hemorrhage Hip Fractures Blood Loss | Study was terminated due to inability to recruit and collect follow up outcome data. - | |||
| NCT02912026 Details | 2019-07-26 Interventional | 1 | 0 | Olorofim Aspergillosis Invasive Asperg… | Major change to study design - | |||
| NCT02613403 2015-001483-19 Details | 2019-07-26 Interventional | 2 | [1 Refs] | 94 | Ribavirin Uprifosbuvir Communicable Di… Digestive Syste… Flaviviridae In… Gastrointestina… Hepatitis Hepatitis A Hepatitis C Hepatitis, Vira… Infections Liver Diseases RNA Virus Infec… Virus Diseases | - - | ||
| NCT01912261 Details | 2019-07-26 Interventional | 3 | 121 | Iron Fatigue | The study was stopped due to time constraints and resources - | |||
| NCT00642694 Details | 2019-07-26 Interventional | 3 | 29 | Citalopram Dexetimide Escitalopram Depression Depressive Diso… Depressive Diso… Sleep Initiatio… Insomnia Major Depressiv… | Enrollment discontinued based on mutually agreed upon decision by PI and funding sponsor - | |||
| NCT03361709 Details | 2019-07-24 Interventional | 4 | 0 | Dexamethasone Corneal Endothe… Corneal Endothe… Dexamethasone A… Diabetes Mellit… | Inability to perform the study at present time. - | |||
| NCT03074825 Details | 2019-07-24 Interventional | 1 | 5 | Chiauranib Lymphoma Lymphoma, Non-H… Non-Hodgkin's L… | The results fell short of expectations. - | |||
| NCT03010761 Details | 2019-07-24 Interventional | 2 | 90 | Escitalopram Moclobemide Behavior, Addic… Addiction | all participants finished the trial - | |||
| NCT02853253 Details | 2019-07-24 Interventional | 4 | 0 | SMOFlipid Bronchopulmonar… Premature Birth Preterm Neonate… | scientific question reconsidered - | |||
| NCT01646125 2012-001050-25 Details | 2019-07-24 Interventional | 2 | 59 | Docetaxel Pemetrexed Carcinoma, Non-… Lung Neoplasms Advanced Non Sm… | An interim analysis was conducted in May-2014. Upon review of the data, the committee
recommended study termination due to futility. The data monitoring committee (DMC's) recommendation based on the Interim Analysis (IA) results to terminate the study early due to futility, data was not collected for this assessment on many of the secondary endpoints. | |||
| NCT00882076 Details | 2019-07-24 Interventional | 1 | 22 | Clofarabine Etoposide Etoposide phosp… Mitoxantrone Leukemia | study closed prematurely - | |||
| NCT02664961 Details | 2019-07-23 Interventional | 2 | 3 | Bevacizumab Choriocarcinoma Gestational Tro… Neoplasms Trophoblastic N… Trophoblastic T… Epithelioid Tro… Gestational Tro… Placental Site … | Rare tumor type, patients eligible via expanded access. - | |||
| NCT02610062 Details | 2019-07-23 Interventional | 1 | 23 | AGS67E Leukemia Leukemia, Myelo… Leukemia, Myelo… Acute Myeloid L… | Business decision by sponsor - | |||
| NCT02543086 Details | 2019-07-23 Interventional | 1 | 8 | Piperaquine Malaria Malaria, Falcip… Plasmodium Falc… | - - | |||
| NCT02111447 Details | 2019-07-23 Interventional | 4 | 6 | Isoflurane Propofol Sevoflurane Delirium Emergence Delir… Delirium on Eme… | Not enough participants none study not completed due to facility issues | |||
| NCT00668317 2006-004102-13 Details | 2019-07-23 Interventional | 3 | 5 | Omeprazole Ranitidine Ranitidine bism… Bronchial Hyper… Cough | Primary care physicians began prescribing antacid therapy for chronic cough - | |||
| NCT03794596 2018-004121-80 Details | 2019-07-22 Interventional | 2 | 0 | Aspirin Avelumab Dexlansoprazole Lansoprazole Proton Pump Inh… Breast Neoplasm… Triple Negative… Breast Cancer | IP breach - | |||
| NCT03855865 2018-000063-88 Details | 2019-07-19 Interventional | 3 | 0 | Vortioxetine Depression Depressive Diso… Depressive Diso… | Business decision to stop the program. - |